|
|
|
In the US, the prevalence of serogroup Y has increased over the last few years (from 9% of reported cases in 1990-92 to 39% in 2006)[3]. The dynamic and unpredictable nature of meningococcal disease epidemiology warrants a vaccine that offers broad serogroup protection[6].meningitis. In particular, management's expectations regarding Menveo could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally, including an unexpected inability to meet the requirements of the FDA: unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission.
References [1. Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book: Course Textbook). Such statements include, but are not limited to, those relating to Aeolus' product candidates, as well as its proprietary technologies and research programs.
ativan or xanax buy xanax valium is klonopin stronger than xanax phentermine and xanax tapering discontinuation xanax xanax does not help with palpitations xanax duration
meningitis. Nor can there be any guarantee that Menveo will achieve any particular levels of revenue in the future. 10th Edition, 2nd printing. Additionally, mice receiving AEOL 10150 experienced a reversal in weight loss seen in the untreated mice.D. Vujaskovic at the 55th Annual Meeting of the Radiation Research Society in October 2009 in Savannah, Georgia.05) survival advantage, statistically significant differences in body weights and wet lung weights were seen over the first six weeks of the study.
-- Multiple Applications – AEOL 10150 has demonstrated protective effects against radiation and mustard gas exposure, and within these indications has shown the ability to treat multiple organ systems.
|
|
No News has been posted yet
|
|
|
Forgotten your password? Request a new one here.
|
 Guests Online: 1
No Members Online
Registered Members: 1
Unactivated Members: 0
Newest Member: Owen Electrical
|
|
v6.01.1 © 2003-2005